Tag: Reblozyl

EC approves Reblozyl for transfusion-dependent anemia in adults

pharmanewsdaily- June 28, 2020

Bristol Myers Squibb and Acceleron Pharma have secured approval from the European Commission (EC) for their jointly developed erythroid maturation agent Reblozyl (luspatercept) for the ... Read More

Celgene, Acceleron bag Reblozyl FDA approval for anemia in beta thalassemia

pharmanewsdaily- November 9, 2019

Reblozyl FDA approval : Celgene and Acceleron Pharma have bagged approval from the US Food and Drug Administration (FDA) for Reblozyl (luspatercept-aamt) for the treatment ... Read More